Two Diseases-One Preclinical Treatment Targeting Glycogen Synthesis.
作者信息
Gentry Matthew S, Markussen Kia H, Donohue Katherine J
机构信息
Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY, USA.
出版信息
Neurotherapeutics. 2022 Apr;19(3):977-981. doi: 10.1007/s13311-022-01240-9. Epub 2022 Apr 22.
Abstract
摘要
相似文献
1
Two Diseases-One Preclinical Treatment Targeting Glycogen Synthesis.两种疾病——针对糖原合成的一种临床前治疗靶点。
Neurotherapeutics. 2022 Apr;19(3):977-981. doi: 10.1007/s13311-022-01240-9. Epub 2022 Apr 22.
2
Targeting Gys1 with AAV-SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models.靶向 Gys1 用 AAV-SaCas9 减少成年多糖尿素体病和拉佛拉病小鼠模型中的致病性多聚糖体和神经炎症。
Neurotherapeutics. 2021 Apr;18(2):1414-1425. doi: 10.1007/s13311-021-01040-7. Epub 2021 Apr 8.
3
Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency.RBCK1 缺陷症患者骨骼肌中的多聚葡聚糖体的蛋白质组学特征。
Neuropathol Appl Neurobiol. 2022 Feb;48(1):e12761. doi: 10.1111/nan.12761. Epub 2021 Sep 12.
4
Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases.骨骼肌糖原链长与多聚糖相关神经退行性疾病小鼠模型中的不溶性相关。
Cell Rep. 2019 Apr 30;27(5):1334-1344.e6. doi: 10.1016/j.celrep.2019.04.017.
5
Update on polyglucosan storage diseases.多黏糊精贮积症的最新进展。
Virchows Arch. 2019 Dec;475(6):671-686. doi: 10.1007/s00428-019-02633-6. Epub 2019 Jul 30.
6
Glycogen hyperphosphorylation underlies lafora body formation.糖原过度磷酸化是形成拉佛拉体的基础。
Ann Neurol. 2010 Dec;68(6):925-33. doi: 10.1002/ana.22156.
7
Sensitive quantification of α-glucans in mouse tissues, cell cultures, and human cerebrospinal fluid.灵敏检测鼠组织、细胞培养物和人脑脊液中的α-葡聚糖。
J Biol Chem. 2020 Oct 23;295(43):14698-14709. doi: 10.1074/jbc.RA120.015061. Epub 2020 Aug 13.
8
Role of Astrocytes in the Pathophysiology of Lafora Disease and Other Glycogen Storage Disorders.星形胶质细胞在拉佛拉病和其他糖原贮积症的病理生理学中的作用。
Cells. 2023 Feb 24;12(5):722. doi: 10.3390/cells12050722.
9
Polyglucosan storage myopathies.多聚葡聚糖贮积性肌病。
Mol Aspects Med. 2015 Dec;46:85-100. doi: 10.1016/j.mam.2015.08.006. Epub 2015 Aug 13.
10
Glycogen metabolism in tissues from a mouse model of Lafora disease.来自拉福拉病小鼠模型的组织中的糖原代谢
Arch Biochem Biophys. 2007 Jan 15;457(2):264-9. doi: 10.1016/j.abb.2006.10.017. Epub 2006 Nov 3.
引用本文的文献
1
Zebrafish navigating the metabolic maze: insights into human disease - assets, challenges and future implications.斑马鱼在代谢迷宫中探索：对人类疾病的见解——优势、挑战及未来影响
J Diabetes Metab Disord. 2024 Dec 16;24(1):3. doi: 10.1007/s40200-024-01539-8. eCollection 2025 Jun.
2
Case report: Expanding the understanding of the adult polyglucosan body disease continuum: novel presentations, diagnostic pitfalls, and clinical pearls.病例报告：拓展对成人多聚糖体病连续谱的认识：新的表现形式、诊断陷阱及临床要点
Front Genet. 2023 Dec 18;14:1282790. doi: 10.3389/fgene.2023.1282790. eCollection 2023.
3
Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model.Gys1 反义疗法可预防拉佛拉病小鼠模型中的致病聚集物和癫痫样放电。
Neurotherapeutics. 2023 Oct;20(6):1808-1819. doi: 10.1007/s13311-023-01434-9. Epub 2023 Sep 12.
本文引用的文献
1
Inhibiting glycogen synthesis prevents Lafora disease in a mouse model.抑制糖原合成可预防小鼠模型中的拉福拉病。
Ann Neurol. 2013 Aug;74(2):297-300. doi: 10.1002/ana.23899.
Zotero 插件